Author

Henry B. Hochstatter

University of OregonORCID 0000-0003-2625-5573Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Athena Hajarizadeh· 1 shared Chandler L. AsnesiD· 1 shared Johnathan R. O’Hara-SmithiD· 1 shared Justin E. SvendseniD· 1 shared Madeleine R. FordiD· 1 shared Marian H. HettiaratchiiD· 1 shared Robert E. GuldbergiD· 1 shared Samuel R. NightheartiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Athena Hajarizadeh

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringJournal of Controlled ReleasePeer-reviewedJul 14, 2026

Phased affinity-controlled delivery of vascular endothelial growth factor, fibroblast growth factor-2, and platelet derived growth factor enhances in vitro angiogenesis

Justin E. Svendsen, Chandler L. Asnes, Samuel R. Nightheart…·Marian H. Hettiaratchi

This study develops affibody-conjugated hydrogels to phase the delivery of VEGF, FGF-2, and PDGF, enhancing in vitro angiogenesis by 2.8-fold in vascular network length and 4.1-fold in branching.

3 citationstop 5%

𝕏 PostBluesky